OTHER INGREDIENTS: Hypromellose (capsule), microcrystalline cellulose, stearic acid, silica
NO-Level in Tissue, Increased or Decreased, Was Regularly Normalized Through BPC 157 Administration, Along with Increased MDA-Level Decrease (and/or Normalization) Through BPC 157 Administration As emphasized before [11,29], the BPC 157/eNOS relationship is highly related to ongoing healing (and therefore increased, decreased, or not affected) (see Section 2.7), as and the effect of the NO-level in tissue, whether increased or decreased, is regularly normalized by BPC 157 administration, along with decreasing (and/or normalizing) the increased MDA-level
Peptides should be stored in clean, chemically inert containers
Product quality, delivery method, dosage, cycle length, and medical history all affect safety
Each batch is rigorously reviewed for accurate dosing, absence of heavy metals or contaminants, and microbial safety, ensuring the highest quality and safety standards are met
